Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.5 USD | -2.40% | -2.85% | +14.33% |
01:58pm | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
06/05 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.33% | 676.58Cr | |
+29.03% | 4.82TCr | |
-0.10% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.26% | 2.88TCr | |
+11.48% | 2.56TCr | |
-22.74% | 1.9TCr | |
+9.06% | 1.29TCr | |
+30.01% | 1.2TCr | |
-1.51% | 1.18TCr |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Goldman Sachs Adjusts Price Target on Blueprint Medicines to $83 From $93, Maintains Buy Rating